Publicacións (197) Publicacións de María José Alonso Fernández

2024

  1. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

    Vaccines, Vol. 12, Núm. 1

  2. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)

    npj Vaccines

  3. Controlling the protein corona of polymeric nanocapsules: effect of polymer shell on protein adsorption

    Drug Delivery and Translational Research, Vol. 14, Núm. 4, pp. 918-933

  4. Editorial note

    Drug Delivery and Translational Research

  5. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

    npj Vaccines, Vol. 9, Núm. 1

  6. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals

    Advanced Materials, Vol. 36, Núm. 14

2023

  1. Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43

    Pharmaceutics, Vol. 15, Núm. 6

  2. Biofunctionalization of 3D printed collagen with bevacizumab-loaded microparticles targeting pathological angiogenesis

    Journal of Controlled Release, Vol. 360, pp. 747-758

  3. Editorial note

    Drug Delivery and Translational Research

  4. Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages

    Drug Delivery and Translational Research, Vol. 13, Núm. 7, pp. 1896-1911

  5. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors

    Frontiers in Immunology, Vol. 14

  6. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

    Journal of Controlled Release, Vol. 357, pp. 67-83

2022

  1. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer

    Nature Communications, Vol. 13, Núm. 1

  2. Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer (Nature Communications, (2022), 13, 1, (4829), 10.1038/s41467-022-31859-3)

    Nature Communications

  3. Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat

    ACS Nano, Vol. 16, Núm. 9, pp. 14210-14229

  4. Quantification of the actual composition of polymeric nanocapsules: a quality control analysis

    Drug Delivery and Translational Research, Vol. 12, Núm. 11, pp. 2865-2874

  5. Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA

    Drug Delivery and Translational Research, Vol. 12, Núm. 4, pp. 862-880

2021

  1. A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 524-545

  2. Asymmetric flow field-flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 373-395

  3. Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery

    Drug Delivery and Translational Research, Vol. 11, Núm. 4, pp. 1689-1702